People are drawn to ketamine for two distinct reasons: it produces a unique altered state that many find profoundly pleasurable or meaningful, and it has powerful antidepressant effects that can lift severe depression within hours rather than weeks. These two draws overlap but aren’t identical. Some people seek ketamine for the experience itself, others for lasting relief from mental illness, and many find that the subjective experience and the therapeutic benefit are intertwined.
What Ketamine Feels Like
Ketamine produces a constellation of sensations unlike most other substances. At lower doses, users most frequently report feeling happy, relaxed, and “laid back,” along with enhanced perceptual awareness. Colors may appear more vivid, music more immersive, and thoughts more fluid. Many people describe feeling energized, creative, full of ideas, and even “all-powerful,” as though they could accomplish anything. There’s often a sense of being able to understand the world more clearly, a feeling of expanded perspective that some users find genuinely revelatory.
These effects emerge because ketamine blocks a specific type of receptor in the brain involved in how nerve cells communicate. When those receptors are partially blocked, the brain’s excitatory signaling shifts in unusual ways, producing waves of activity that don’t occur during normal consciousness. The result is a dissociative state: a loosening of the usual connection between your sense of self and your body, your thoughts and your surroundings.
At higher doses (typically above 150 mg), this dissociation deepens into what’s known as a “k-hole,” where users experience intense detachment to the point that their perceptions seem located deep within their own consciousness, with external reality appearing far off in the distance. People in this state report a sense of floating, complete separation of mind and body, feelings of peace and love, a sense of oneness with others, and what they describe as unexplainable transcendental experiences. For some, these are among the most meaningful experiences of their lives. For others, they’re disorienting and frightening, sometimes involving a distorted sense of time and a total loss of connection to reality.
Why It Appeals to People With Depression
Traditional antidepressants typically take four to six weeks to produce noticeable changes in mood. Ketamine works on a completely different timeline. In a major clinical study, 52% of participants with severe depression achieved full remission after just three infusions over 11 days. Another 15% showed meaningful improvement. That 67% response rate, with effects appearing within hours to days rather than weeks, represents something genuinely new in psychiatry.
For people who have cycled through multiple medications without relief, this speed is transformative. Treatment-resistant depression, by definition, means standard approaches have failed. When someone has been severely depressed for months or years and suddenly feels it lift in a single afternoon, the appeal is self-evident.
The FDA has approved a nasal spray containing esketamine (a close molecular relative of ketamine) specifically for treatment-resistant depression in adults and for depressive symptoms in people with major depressive disorder who have acute suicidal thoughts. Ketamine itself, administered by IV infusion, is not FDA-approved for any psychiatric condition, though clinicians widely use it off-label. Compounded ketamine products, including those prescribed through telehealth for at-home use, have not been evaluated by the FDA for safety or effectiveness.
How It Changes the Brain
Ketamine’s appeal for depression goes beyond simply making people feel good temporarily. At low doses, it triggers a cascade of biological changes that can restructure how brain cells connect to each other. Within hours of a dose, the brain ramps up production of a growth factor that supports nerve cell health and the formation of new connections between neurons. This protein is essential to ketamine’s antidepressant effects. In animal studies, when researchers removed the gene responsible for producing it, ketamine’s mood-lifting benefits disappeared entirely.
The drug also promotes the insertion of new receptors at synapses, effectively strengthening the lines of communication between brain cells. This process, sometimes called synaptic potentiation, occurs in brain regions critical for memory and mood regulation. It’s a form of rapid rewiring: depression is associated with the loss of synaptic connections in certain brain areas, and ketamine appears to reverse that loss, promoting the growth of new synapses and even new dendritic spines (the tiny projections where neurons receive signals from other neurons).
This is part of why some people experience lasting improvement after a limited course of treatment rather than needing to take the drug continuously. The experience wears off in hours, but the structural brain changes can persist for days or weeks.
The Recreational Draw
Outside of clinical settings, ketamine’s popularity stems from its unusual position among psychoactive substances. It’s not a stimulant, not quite a psychedelic, and not a traditional sedative. It occupies its own category: a dissociative that can feel dreamy and introspective at low doses and profoundly reality-altering at higher ones. Users often describe it as offering a temporary vacation from their own thought patterns, a break from the relentless internal monologue that characterizes anxious or depressive thinking.
The dissociative quality is key. Unlike alcohol, which dulls cognition broadly, or psychedelics, which intensify and sometimes overwhelm perception, ketamine creates a sense of gentle separation. Many users report that problems that normally feel overwhelming seem distant and manageable during and after the experience. This psychological distance can feel like relief, particularly for people carrying chronic stress, trauma, or emotional pain, even if they wouldn’t describe themselves as clinically depressed.
Social context matters too. Ketamine is commonly used in club and festival settings, where its combination of relaxation, enhanced sensory perception, and mild euphoria complements music and social interaction. At these lower, “bumping” doses, users typically feel loose, sociable, and pleasantly altered without losing functional awareness.
Risks That Come With Regular Use
The same properties that make ketamine appealing also make it habit-forming for some people. Tolerance builds relatively quickly, meaning users need progressively larger doses to achieve the same effects. This escalation carries real physical consequences.
The most well-documented long-term risk is bladder damage. Chronic ketamine use can cause a condition called ketamine-induced cystitis, where the bladder walls become severely thickened and inflamed. Symptoms include intense lower abdominal pain, blood in the urine, and in advanced cases, significant damage to the ureters (the tubes connecting the kidneys to the bladder). Imaging of chronic users has revealed dramatic thickening of both the bladder walls and ureters, with swelling extending up toward the kidneys. This damage can be irreversible in severe cases.
Cognitive effects are another concern. Frequent recreational users report problems with memory, concentration, and mental clarity that can persist even during periods of abstinence. The same synaptic remodeling that produces therapeutic benefits at carefully managed low doses may work differently when the brain is repeatedly flooded with higher amounts.
Why the Therapeutic and Recreational Lines Blur
One of the more interesting aspects of ketamine is that the subjective experience and the clinical benefit may not be fully separable. Some researchers have proposed that the dissociative state itself plays a role in the antidepressant effect, that the temporary shift in perspective helps break rigid patterns of negative thinking. Others argue the mood benefits are purely biological, driven by synaptic growth factors and receptor changes, and that the “trip” is just a side effect.
This ambiguity is part of what makes ketamine culturally fascinating. A person using ketamine at a clinic for treatment-resistant depression and a person using it at home to decompress after a difficult week may be seeking variations of the same thing: temporary relief from painful mental states, delivered through a substance that genuinely changes brain chemistry in ways that outlast the high. The difference lies in dosing, medical oversight, and intention, but the underlying appeal, a rapid and tangible shift in how you feel and think, is remarkably consistent across contexts.